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Abstract
Objective: To translate the London Chest Activity of Daily Living (LCADL) scale into Portuguese and to determine whether this version is 
reproducible in Brazilian patients with severe chronic obstructive pulmonary disease (COPD). Methods: The LCADL scale was translated into 
Portuguese and then back-translated into English. This pilot Brazilian Portuguese version was administered to 8 patients with COPD, and 
possible text-related problems were investigated. The principal problems were discussed with the authors of the original scale, and a final 
translated version was arrived at. At the study outset, two observers administered this final version (twice in one day) to 31 patients with 
COPD. One of those observers again administered the scale to the same patients 15-20 days later. At baseline, the patients were submitted 
to pulmonary function testing and to the six-minute walk test (6MWT). Results: The Brazilian Portuguese version of the LCADL scale 
demonstrated excellent reproducibility in the total score and in most of the questions, with an inter-rater Cronbach’s alpha coefficient of 
0.97 (95% CI: 0.89-0.97; p < 0.01) and an intra-rater Cronbach’s alpha coefficient of 0.96 (95% CI: 0.83-0.96; p < 0.01). The total score 
presented a negative correlation with forced expiratory volume in one second in liters (r = −0.49; p < 0.05) and with distance covered on the 
6MWT (r = −0.56; p < 0.05). Conclusion: The Brazilian Portuguese version of the LCADL scale is a reliable, reproducible, and valid instrument 
for evaluating dyspnea during activities of daily living in patients with severe COPD.
Keywords: Activities of daily living; Dyspnea; Diagnostic techniques and procedures; Reproducibility of results.
Resumo
Objetivo: Traduzir a escala London Chest Activity of Daily Living (LCADL) para o português e verificar se essa versão é reprodutível em 
pacientes com doença pulmonar obstrutiva crônica (DPOC) grave no Brasil. Métodos: Foram realizadas a tradução da escala LCADL para o 
português e a tradução retrógrada dessa versão em português para o inglês. Essa primeira versão em português foi aplicada a 8 pacientes 
com DPOC, e possíveis dificuldades em relação ao texto foram investigadas. As principais dificuldades encontradas foram discutidas com os 
autores da escala, chegando-se a uma versão final do instrumento. Essa versão final foi aplicada duas vezes a 31 pacientes com DPOC por 
dois observadores separadamente em um primeiro dia. Após 15-20 dias, essa mesma versão foi aplicada novamente aos mesmos pacientes 
por um dos observadores. No primeiro dia os pacientes foram submetidos à prova de função pulmonar e ao teste de caminhada de seis 
minutos (TC6). Resultados: A versão brasileira da escala LCADL demonstrou excelente reprodutibilidade no escore total e na maioria das 
questões, com um coeficiente alfa de Cronbach interobservador de 0,97 (IC95%: 0,89-0,97; p < 0,05) e um coeficiente alfa de Cronbach 
intra-observador de 0,96 (IC95%: 0,83-0,96; p < 0,05). O escore total dessa versão apresentou correlação negativa com o volume expiratório 
forçado no primeiro segundo em litros (r = −0,49; p < 0,05) e a distância percorrida no TC6 (r = −0,56; p < 0,05). Conclusão: A versão 
brasileira da escala LCADL é um instrumento confiável, reprodutível e válido para avaliar a dispnéia durante atividades de vida diária em 
pacientes com DPOC grave.
Descritores: Atividades Cotidianas; Dispnéia; Técnicas de diagnóstico e procedimentos; Reprodutibilidade dos Resultados.
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COPD in terms of the degree of dyspnea experi-
enced during the performance of ADLs.
Methods
A total of thirty-one individuals diagnosed 
with severe COPD and treated at the Vale do Itajaí 
University Physical Therapy Clinic in the city of 
Itajaí, located in the state of Santa Catarina, Brazil, 
were included in the study. The inclusion criteria 
were having been diagnosed with severe COPD, in 
accordance with the criteria of the Global Initiative 
for Chronic Obstructive Lung Disease (GOLD),(1) and 
clinical stability for the four weeks preceding the 
study outset. The exclusion criteria were as follows: 
presenting other nonpulmonary diseases that are 
considered disabling, severe, or difficult-to-control; 
presenting exacerbation during the study period; 
being incapable of understanding the scale; and 
being unable to perform the 6MWT.
All participants gave written informed consent, 
and the study was approved by the Ethics in Human 
Research Committee of the Triangle University 
Center.
First, the English version of the LCADL scale was 
translated into Portuguese by two researchers of this 
study. This Brazilian Portuguese version was then 
back-translated into English by a health professional 
who had no prior knowledge of the scale. This pilot 
Brazilian Portuguese version was administered to 
eight patients with COPD, and possible text-related 
problems were investigated. Subsequently, the prin-
cipal problems were discussed with the authors of 
the original scale, and a final translated version was 
arrived at (Appendix). This final version was admin-
istered to the participants of this study.
The volunteers were assessed for prebronchodi-
lator and postbronchodilator pulmonary function 
using a previously calibrated Multispiro spirometer 
(SX/PC; Creative Biomedics, San Clemente, CA, USA), 
in accordance with the guidelines established by the 
Brazilian Thoracic Society.(15) Oxygen saturation was 
also measured, using an Ohmeda pulse oximeter (Biox 
3700; Ohmeda, Boulder, CO, USA), after the patients 
had rested for 15 min. On the same day, the patients 
performed two 6MWTs, after which the LCADL scale 
was administered. At the study outset, the scale was 
administered to the patients (twice in one day) by two 
observers (Obs. 1 and Obs. 2.1). The order of admin-
istration was always the same: first, the scale was 
Introduction
Chronic obstructive pulmonary disease (COPD) 
is characterized by chronic airflow limitation that is 
partially reversible, progressive, and accompanied by 
an abnormal inflammatory response of the lungs to 
noxious particles or gases. It presents some signifi-
cant extrapulmonary effects and severe comorbidities 
that can increase its severity.(1) Nutritional abnormali-
ties, weight loss, and skeletal muscle dysfunction are 
some of the extrapulmonary effects of COPD.(2,3)
Reduced pulmonary function associated with 
peripheral muscle dysfunction limits exercise capacity 
in such individuals. The degree of disease severity 
has a direct effect on the extent to which COPD 
patients are limited by the fatigue and dyspnea 
experienced during the performance of activities of 
daily living (ADLs).(4,5)
The impairment of ADLs in such patients can 
be assessed using the six-minute walk test (6MWT), 
since the distance covered on the test is considered 
a good marker of functional capacity to perform 
ADLs.(6) However, this test does not identify the activ-
ities in which the impairment is present nor does it 
assess the impairment of activities performed using 
the upper limbs, which are typically used extensively 
in performing habitual ADLs.
There are few validated tools for assessing 
functional incapacity in patients with COPD. The 
instruments available have little applicability in 
severely limited patients(7) or present limited sensi-
tivity to changes following interventions, such as 
pulmonary rehabilitation.(8)
Garrod et al. (2000)(9) developed an instrument, 
the London Chest Activity of Daily Living (LCADL) 
scale, which has four domains (personal care, 
household activities, physical activities, and leisure 
activities), with the aim of assessing the impairment 
of ADLs in patients with COPD. The LCADL scale has 
proven to be a reliable, valid, and sensitive instru-
ment for assessing patient response to pulmonary 
rehabilitation programs.(10) Nevertheless, the use of 
a pre-existing instrument that was developed in 
another language and for use in another culture 
should be contemplated only after this instrument 
has been adapted for use in the target culture.(11-14)
The objective of this study was to develop a 
Brazilian version of the LCADL and to determine 
whether the Brazilian version is reproducible and 
valid for use in evaluating patients with severe 
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and were given verbal encouragement through the 
use of standardized phrases and in accordance with 
the American Thoracic Society criteria.(16)
In the statistical analysis, the Wilcoxon test was 
used to compare the scores obtained from the admin-
istration of the LCDAL scale by Obs. 1 and by Obs. 
2.1 and to compare the scores obtained from the 
administration of the scale by the second observer 
on the two days (Obs. 2.1 and Obs. 2.2). The intra-
class correlation coefficient (ICC)(17,18) was used to 
determine the reproducibility of the scale. The kappa 
coefficient was used to determine the concordance 
of the responses to question 16, which was a multi-
ple-choice question (“How much does shortness of 
breath affect your performance of ADLs?”) offering 
the following options: ‘Quite a bit’; ‘Slightly’; and 
‘Not at all’. Bland & Altman plots(19,20) were used in 
order to improve the visualization of the concord-
ance between the scores obtained from the various 
administrations of the scale. Spearman’s correlation 
coefficient was used to determine how the score of 
the LCADL scale correlated with distance covered on 
the 6MWT and with forced expiratory volume in one 
second (FEV1). For the statistical analysis, the level of 
significance was set at 5% (p < 0.05).
Results
Of the sample of thirty-one patients with COPD, 
twenty-four (77%) were male. There were eight 
patients (all males) who were oxygen-dependent for 
the performance of their ADLs. The characteristics 
of the patients are shown in Table 1.
administered by Obs. 1 and, 10 min later, it was admin-
istered by Obs. 2.1. The scale was administered again, 
15-20 days later, by the second observer (Obs. 2.2). 
On the second day of administration of the scale, the 
patients completed a brief questionnaire comparing 
current symptoms (cough, volume and color of secreted 
expectoration, as well as dyspnea) with those reported 
at the study outset. If there were any changes (in the 
symptoms or in the type/dose of medication used), a 
second spirometric test was performed on the second 
day. None of the patients in the sample presented any 
such changes in the symptoms or in the medication 
used between the two study days.
During the various administrations of the scale, 
the observer and the patient were alone. The observers 
read the questions to the individuals who had had 
little schooling, repeating them if necessary but not 
offering any explanations or interpretations.
The LCADL scale consists of 15 questions 
divided into four domains: personal care, household 
activities, physical activities, and leisure activities. 
Patients assign a score to each domain item. Scores 
range from 0 to 5, the highest score indicating the 
greatest incapacity to perform ADLs. The total score 
can reach 75 points. The scale was evaluated in terms 
of total score, domain scores, and scores for indi-
vidual questions. The percentage of the total score 
corresponding to the number of questions to which 
the score given was not 0 was also evaluated.
The 6MWT was performed twice, with a 30-min 
interval, and the value of the greatest distance 
covered was used for analysis. The patients walked 
at their own pace along a corridor (25 min length), 
Table 1 - Anthropometric data of the sample studied, pulmonary function test results, and distance covered on the 
six-minute walk test. 
Characteristic Mean SD Median 95% CI
LL UL
Age (years) 65 7 68 63 68
Smoking (pack-years) 50.0 23.2 45.0 42.0 58.3
BMI (kg/m2) 24 4 23 22 25
FEV1 (L) 1.06 0.40 0.96 0.91 1.21
FEV1 (% of predicted) 38.5 13.1 36.1 33.8 43.1
FVC (L) 2.10 0.8 2.03 1.85 2.39
FVC (% of predicted) 62.9 18.4 61.5 56.3 69.3
FEV1/FVC (%) 62.3 15.9 61.2 56.7 67.9
SpO2 (%) 93.0 2.3 93.5 92.2 93.8
D6MWT (m) 337.83 134.0 376 290.7 385
SD: standard deviation; 95% CI: 95% confidence interval; LL: lower limit; UL: upper limit; BMI: body mass index; FEV1: forced 
expiratory volume in one second; FVC: forced vital capacity; SpO2: peripheral oxygen saturation; D6MWT: distance covered on the 
six-minute walk test. 
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5, and, in one of those, the difference was 21. In 
the intra-rater analysis, four patients presented a 
difference greater than 5, and, in one of those, the 
difference was 29.
Excellent inter-rater and intra-rater reliability 
was also found for the percentage of the total 
score of the LCADL scale, and the ICC was 0.97 and 
0.98 (p < 0.01), respectively. When the total score 
was correlated with the percentage of the total 
score, an r value of 0.87 (p < 0.05) was found.
Question 16 is related to the extent to which 
the performance of ADLs is impaired by dyspnea, 
and patients answer it by checking one of the three 
multiple-choice responses: ‘Quite a bit’; ‘Slightly’; 
or ‘Not at all’. A strong concordance between Obs. 1 
and Obs. 2 (kappa = 0.87; p < 0.001) and a moderate 
intra-rater agreement (kappa = 0.60; p < 0.01) were 
observed for this question.
The total score of the LCADL scale presented a 
negative correlation with FEV1 in liters (r = −0.49; 
p < 0.05) and with distance covered on the 6MWT 
(r = −0.56; p < 0.01). When this correlation was 
analyzed using the percentage of the total score of 
the LCADL scale and distance covered on the 6MWT, 
an r value of −0.75 (p < 0.01) was found.
Discussion
In the present study, we observed that the 
Brazilian version of the LCADL scale presents 
excellent reliability for administration by different 
observers as well as for administration by the same 
observer at two distinct time points. This version 
The means of the total LCADL scores, as well as 
of the domain scores, are shown in Table 2.
The comparison between the means of the 
scores obtained by Obs. 1 and of those obtained 
by Obs.2 revealed no statistically significant differ-
ence in terms of the total score or the percentage 
of the total score. The same was found to be true 
for the comparison between the means of the scores 
obtained by the second observer on the first day 
(Obs. 2.1) and those of the scores obtained by that 
same observer 15-20 days later (Obs. 2.2).
In the analysis of inter-rater reliability, we 
obtained a Cronbach’s alpha coefficient (α) of 
0.97 (95% CI: 0.89-0.97; p < 0.01) for the total 
score of the LCADL scale. In addition, for 13 of the 
15  questions, the ICC was higher than 0.90 (p < 0.01). 
Furthermore, for question 12 (related to dyspnea 
when stooping), the ICC was 0.85 (p < 0.01), and, 
for question 15 (related to speaking/conversing), 
the ICC was 0.67 (p < 0.05). Figure 1 shows the 
inter-rater reliability.
The analysis of intra-rater reliability revealed an 
α of 0.96 (95% CI: 0.83-0.96; p < 0.01) for the 
total score. In addition, only questions 3 (related 
to dyspnea while putting on shoes/socks) and 
12 (related to dyspnea while stooping) obtained an 
ICC lower than 0.90 (0.85 and 0.86, respectively). The 
excellent inter-rater and intra-rater reliability can be 
confirmed in the Bland & Altman plots (Figure 2), 
where it can be seen that most patients presented 
differences of less than or equal to 5 points between 
the two administrations. In the inter-rater analysis, 
three patients presented a difference greater than 
Table 2 - Means of the total scores, of the percentage of the total score, and of the scores of the domains of the 
London Chest Activity of Daily Living in the sample studied, as well as inter-rater and intra-rater intraclass correlation 
coefficients.
Obs. 1 Obs. 2.1 Obs. 2.2 Inter ICC Intra ICC
Total LCADL 26.7 ± 13.9 (21.8-31.6) 27.4 ± 15.3 (22.0-32.8) 26.9 ± 14.8 (21.7-32.1) 0.97a 0.96a
% of total LCADL 45.4 ± 19.0 (38.7-52.1) 45.9 ± 19.8 (38.9-52.9) 45.5 ± 19.7 (38.6-52.4) 0.98a 0.98a
Personal care 8.6 ± 4.5 (7.0-10.2) 8.9 ± 4.5 (7.3-10.5) 8.7 ± 4.6 (7.1-10.3) 0.99a 0.97a
Household activities 7.2 ± 9.2 (4.0-10.4) 7.8 ± 9.9 (4.3-11.3) 7.4 ± 9.6 (4.0-10.8) 0.96a 0.95a
Physical activities 5.0 ± 2.0 (4.3-5.7) 4.9 ± 1.5 (4.4-5.4) 5.2 ± 1.7 (4.6-5.8) 0.92a 0.95a
Leisure activities 5.8 ± 2.8 (4.8-6.8) 5.7 ± 2.8 (4.7-6.7) 5.6 ± 2.8 (4.6-6.6) 0.94a 0.98a
ap < 0.01 in intraclass correlations: excellent correlation (0.8-1.0); good correlation (0.6-0.8), satisfactory correlation (0.4-0.6); and 
weak correlation (0.2-0.4). Obs.1: observer one on the first day; Obs. 2.1: observer two on the first day; Obs. 2.2: observer two 15-20 
days later; Inter ICC: inter-rater intraclass correlation coefficient; Intra ICC: intra-rater intraclass correlation coefficient; Total LCADL: 
means of the total scores of the London Chest Activity of Daily Living scale; and % of total LCADL: means of the percentage of the 
total score of the London Chest Activity of Daily Living scale.Data expressed as mean ± standard deviation (95% confidence interval: 
lower limit-upper limit); and non-significant p value > 0.05 in the comparison between the scores obtained by Obs. 1 and by Obs. 2 
and between the scores obtained by Obs. 2.1 and by Obs. 2.2 (Wilcoxon test).
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careful to note the principal questions the partici-
pants had regarding the items of the instrument 
and to discuss those questions with the authors of 
the original scale, thus arriving at a final translated 
version.
In the systematic approach to validating ques-
tionnaires and scales, discussion with the original 
authors is not the norm; most studies involve 
evaluation by bilingual observers with the aim of 
obtaining a harmonious text that is easily under-
stood.(22,23) In other studies, however, this goal of 
achieving linguistic harmony while maintaining the 
essence of the instrument has been achieved with 
the participation of the original authors.(13,24)
Initially, the principal difficulty found was 
related to the differentiation of the score for each 
ADL by the individuals of the sample, especially 
for the scores 0 (‘I would not do that under any 
circumstances.’), 4 (‘I cannot do that anymore.’), 
and 5 (‘Someone does that for me.’) Difficulties 
in interpreting the items evaluated have also been 
identified in other studies, and those items need 
to be rephrased in order to be more easily under-
stood.(12,13) In order to minimize the possibility of 
misinterpretation of the scores, it was necessary to 
adapt the first translation of the LCADL scale after 
the pilot study was carried out. The final translated 
version was arrived at in collaboration with the 
authors of the original version. Therefore, the items 
were made to read as follows: (score 0) ‘I do not 
perform this activity (because I have never needed 
to or it is irrelevant).’; (score 4) ‘Due to shortness of 
also proved to be valid, correlating with distance 
covered on the 6MWT and with FEV1.
The evaluation of the inter-rater reliability of the 
total score revealed an ICC of 0.97, which shows 
excellent reliability. In the intra-rater analysis, the 
ICC presented a value similar to that found by 
Garrod et al. (2002),(10) who, in analyzing the repro-
ducibility of the LCADL scale in nineteen  individuals, 
also obtained excellent reliability (α = 0.96).(21) 
The inter-rater and intra-rater agreement for the 
various administrations of the scale was confirmed 
using Bland & Altman plots. However, the upper 
and lower limits of the inter-rater and intra-rater 
analyses were relatively high, considering that the 
maximum score is 75 points. Nevertheless, this 
does not represent a tendency of the sample as a 
whole since only one patient presented consider-
able discrepancies among the scores obtained at the 
three time points at which the scale was adminis-
tered (30, 51, and 22 points, respectively). The high 
values of the differences among the various admin-
istrations (inter-rater difference of 21 points and 
intra-rater difference of 29 points) for this patient 
(age, 57 years; body mass index, 20 kg/m2; FEV1, 
36% of predicted) might have been responsible for 
increasing the 95% CI of the sample.
The satisfactory reliability of the LCADL scale can 
be explained by the relative simplicity of the items 
included in each domain; it was always clear to the 
patients which ADL a given item was referring to.(10) 
In addition, during the process of translating the 
scale, we conducted a pilot study, in which we were 































































Figure 1 - Intraclass correlation of the scores: a) Administration of the London Chest Activity of Daily Living (LCADL) 
scale by observer one (Obs. 1) and by observer two (Obs. 2) on the first day (α = 0.97 and p < 0.01); and b) Administration 
of the scale by observer two on the first day (Obs. 2.1) and 15-20 days later (Obs. 2.2) (α = 0.96 and p < 0.01).
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of dyspnea in patients with COPD, facilitating the 
performance of ADLs.(25,26) Oxygen support was not 
considered a relevant factor in the conception of the 
original LCADL scale. However, after discussing it 
with its authors, we decided that this support could 
be interpreted as being an aid to performing the 
activity, without which the activity might be more 
difficult or even impossible.
Another relevant point is that, after the admin-
istration of the LCADL scale, we noticed that some 
individuals, despite giving a score of 5 for most 
of the domains, presented a low total score. This 
occurred primarily among males who had never 
performed household activities, such as making a 
bed or changing the sheets, even prior to having 
symptoms of COPD. This led them to give a score 
of 0 for most of the items of this domain, consider-
ably reducing the total score. Therefore, we suggest 
that the percentage of the total score also be used 
to interpret the scale, disregarding the questions in 
which the score is 0, as was done in the present 
study. We believe that the percentage of the total 
score can provide a better idea of the impairment of 
ADL, improving the interpretation of the degree of 
impairment of the patients.
For question 16, where the individuals performed 
a qualitative evaluation of how much short-
ness of breath affected the performance of their 
ADLs, we observed excellent inter-rater agreement 
(kappa = 0.87) and good intra-rater agreement 
breath, I cannot perform this activity anymore, and 
I do not have anyone to do it for me.’; and (score 5) 
‘Due to shortness of breath, I cannot perform this 
activity anymore, and I need someone to help me or 
to do it for me.’ These alterations allowed a better 
understanding on the part of the patients, making 
the score more illustrative. According to the authors 
of the original LCADL scale, these alterations did 
not change the objectives set, but rather facilitated 
the understanding on the part of the patients. In 
another study by Garrod et al. (2002),(10) sentences 
of a more illustrative nature were added to the 0 to 
5 score, something that had not been done in the 
original scale.
Another difficulty identified in the pilot study 
was the determination of the score for those patients 
who were oxygen-dependent for the performance 
of their ADLs. In the original study by Garrod et al. 
(2000),(9) this difficulty was not observed, since, in 
the sample, there were no individuals who used 
oxygen. In the pilot phase of the present study, 
we found that the use of oxygen influenced the 
choice of the score since many oxygen-dependent 
patients reported not having dyspnea or reported 
having only mild dyspnea while performing certain 
activities. However, when those patients were asked 
whether they would be able to perform such activi-
ties without oxygen support, they said that they 
would not, due to dyspnea. Studies have demon-
















































Individual means of the scores of the LCADL 
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Figure 2 - Visualization, using Bland & Altman plots, of the scores obtained in the various administrations of the 
London Chest Activity of Daily Living (LCADL) scale by observer one and observer two on the first day (Obs. 1 and 
Obs. 2) and by observer two 15-20 days later (Obs. 2.2): a) Inter-rater analysis: mean = 0.68; upper limit = 9.82 and 
lower limit = −8.46; and b) Intra-rater analysis: mean = −0.58; upper limit = 11.8 and lower limit = −12.9.
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questionnaires, might not be as appropriate for 
assessing patients who are more severely impaired. 
In addition, these instruments should have sensi-
tivity to assess response to interventions, such as 
pulmonary rehabilitation, which is one of the main 
therapeutic approaches to minimizing COPD patient 
intolerance to ADLs. The Nottingham Extended 
Activities of Daily Living scale,(28) despite having 
been shown to differentiate among patients with 
COPD on the basis of the level of functional impair-
ment, was not found to be sensitive enough to 
detect improvement after pulmonary rehabilita-
tion.(29) Another such instrument is the Manchester 
Respiratory Activities of Daily Living questionnaire, 
which is, however, aimed at assessing only elderly 
patients with COPD.(30)
Further studies are needed in order to determine 
the sensitivity of the Brazilian Portuguese version of 
the LCADL scale in determining patient responses 
to therapeutic interventions. However, we believe 
that interpreting a score of 5 (‘I cannot perform 
this activity anymore due to shortness of breath 
and need someone to do it for me or help me’) 
as including the use of supplemental oxygen can 
limit the use of this instrument in assessing patient 
response to oxygen therapy.
In conclusion, the Brazilian Portuguese version 
of the LCADL scale is a reliable and valid instrument 
for evaluating dyspnea during the performance of 
ADLs by patients with severe COPD.
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The Brazilian Portuguese version of the London Chest Activity of Daily Living  
scale for use in patients with chronic obstructive pulmonary disease




Do you live alone? ( ) Yes ( ) No
Personal care
1) Drying yourself after the shower __________
2) Clothing the upper part of your body (T-shirt, coat) __________
3) Putting on shoes/socks __________
4) Washing your hair __________
Household activities
5) Making your bed __________
6) Changing the sheets __________
7) Washing windows/curtains __________
8) Dusting __________
9) Doing the dishes ___________
10) Vacuum cleaning/sweeping __________
Physical activities
11) Climbing stairs __________
12) Bending over __________
LEISURE ACTIVITIES
13) Walking in the home __________
14) Going out __________
15) Speaking/talking __________
General
16) How much does shortness of breath affect your performance of activities of daily living?
( ) Quite a bit ( ) Slightly ( ) Not at all
Score
0) I do not perform this activity (because I have never needed to or it is irrelevant).
1) I do not experience shortness of breath while performing this activity.
2) I experience mild shortness of breath while performing this activity.
3) I experience severe shortness of breath while performing this activity.
4) Due to shortness of breath, I cannot perform this activity anymore, and I do not have anyone to do it for me.
5) Due to shortness of breath, I cannot perform this activity anymore, and I need someone to help me or to do it for me.
Appendix
